Abstract
To summarise available evidence on the accuracy and the clinical utility, as well as assess the economic aspect of molecular testing (immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), reverse transcription-polymerase chain reaction (RT-PCR) and next-generation sequencing (NGS)) for the identification of NTRK neurotrophic tyrosine receptor kinase (NTRK) gene fusions in patients with locally advanced or metastatic solid tumours.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
